BlackRock Health Sciences Opportunities Portfolio Investor A Shares (SHSAX)

Fund Assets	6.26B
Expense Ratio	1.122%
Min. Investment	$1,000
Turnover	49.00%
Dividend (ttm)	0.19
Dividend Yield	0.29%
Dividend Growth	27.14%
Payout Frequency	Semi-Annual
Ex-Dividend Date	Jul 22, 2026

Previous Close	64.74
YTD Return	12.60%
1-Year Return	22.68%
5-Year Return	40.51%
52-Week Low	60.07
52-Week High	69.81
Beta (5Y)	0.69
Holdings	142
Inception Date	Dec 21, 1999

About SHSAX

The fund primarily aims to generate significant capital appreciation for investors over an extended timeframe. To achieve this, it commits at least 80% of its overall assets to equity instruments, predominantly common stocks, of companies engaged in the health sciences and related fields. This specialized sector encompasses a broad spectrum of businesses, such as those involved in medical equipment and supplies, healthcare service delivery, advanced biotechnology, and pharmaceutical manufacturing. The portfolio maintains a concentrated investment approach, allocating more than 25% of its holdings to these health sciences and associated industries, and it also retains the flexibility to invest in companies based outside the United States.

• Fund Family: BlackRock
• Category: Health
• Performance Rating: Above Average
• Risk Rating: Low
• Stock Exchange: Nasdaq
• Ticker Symbol: SHSAX
• Share Class: Investor A
• Index: Russell 3000 Healthcare TR

Performance

SHSAX had a total return of 22.68% in the past year, including dividends. Since the fund's inception, the average annual return has been 13.25%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
SHSSX	Institutional	0.86%
SHISX	Service	1.16%
SHSCX	Investor C	1.90%

Top 10 Holdings

53.34% of assets

Name	Symbol	Weight
Eli Lilly and Company	LLY	11.92%
Johnson & Johnson	JNJ	8.03%
Merck & Co., Inc.	MRK	5.56%
AbbVie Inc.	ABBV	5.07%
Thermo Fisher Scientific Inc.	TMO	4.41%
UnitedHealth Group Incorporated	UNH	4.33%
Gilead Sciences, Inc.	GILD	4.09%
Amgen Inc.	AMGN	3.98%
Vertex Pharmaceuticals Incorporated	VRTX	3.33%
Abbott Laboratories	ABT	2.61%

Dividend History

Ex-Dividend	Amount	Pay Date
Jul 22, 2026	$6.46449	Jul 23, 2026
Dec 9, 2025	$3.04694	Dec 10, 2025
Jul 17, 2025	$3.83665	Jul 18, 2025
Dec 11, 2024	$3.2425	Dec 12, 2024
Jul 18, 2024	$2.49135	Jul 19, 2024
Dec 7, 2023	$1.17094	Dec 8, 2023

Data Sources: Tiingo, Financial Modeling Prep, and more

Historical data is provided by Tiingo. Delayed stock pricing data is provided by Financial Modeling Prep. Several fund data points are also provided by Finnhub.

Last checked:

Oct 15, 2026

Data Sources Report a data error